Position
PRUDENTIAL PLC in Royalty Pharma PLC
Back to the book · All holders of RPRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $98.7K$38.64 → $47.97
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 10.6K | $408.6K | — | — | — | 0.0% |
| Q1 2026 | 10.6K | $507.3K | $47.97 | $98.7K | $0 | 0.0% |